Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacist-based i.v. theophylline therapy.

T Donahue, J Dotter, G Alexander

    Hospital Pharmacy
    |May 9, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Burnout syndrome among Tobagonian healthcare-workers during the COVID-19 pandemic.

    Scientific reports·2026
    Same author

    A South Africa tertiary centre experience with redo mitral valve replacement.

    South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie·2022
    Same author

    Do specialist pulmonologists appropriately utilise thoracic surgery for drug-resistant pulmonary tuberculosis? A survey.

    African journal of thoracic and critical care medicine·2021
    Same author

    Reflections on the Experience of Community Health Nurses in Palliative Care: A Qualitative Approach.

    Indian journal of palliative care·2021
    Same author

    Measurement of <math></math> production with the hadronically decaying boson reconstructed as one or two jets in <i>pp</i> collisions at <math> </math> with ATLAS, and constraints on anomalous gauge couplings.

    The European physical journal. C, Particles and fields·2020
    Same author

    Study of <math></math> and <math></math> production in <math></math> collisions at <math> </math> and search for anomalous quartic gauge couplings with the ATLAS experiment.

    The European physical journal. C, Particles and fields·2020

    A new protocol for intravenous theophylline dosing and monitoring was implemented. This approach ensured that 84% of patients remained within the target therapeutic range of 10-20 mcg/mL.

    Area of Science:

    • Pharmacology
    • Clinical Pharmacy Practice
    • Patient Safety

    Background:

    • Theophylline is a critical medication requiring careful dosing.
    • Inconsistent theophylline levels can lead to toxicity or sub-therapeutic effects.
    • A standardized protocol is needed for safe and effective IV theophylline administration.

    Purpose of the Study:

    • To implement and evaluate a protocol for intravenous theophylline dosing and monitoring.
    • To ensure consistent therapeutic theophylline levels in patients.
    • To improve patient safety and treatment efficacy.

    Main Methods:

    • Development and implementation of a pharmacist-driven protocol for IV theophylline.
    • Individualized dosing based on clinical criteria and patient history.

    Related Experiment Videos

  • Ongoing monitoring and dosage adjustments.
  • Quality assurance audits to assess adherence to therapeutic range.
  • Main Results:

    • The implemented protocol successfully maintained therapeutic theophylline levels (10-20 mcg/mL) in 84% of patients.
    • Pharmacist involvement ensured individualized dosing and monitoring.
    • Quality assurance audits validated the protocol's effectiveness.

    Conclusions:

    • A pharmacist-led protocol for IV theophylline dosing and monitoring is effective.
    • This protocol significantly improves the maintenance of therapeutic theophylline levels.
    • Implementation enhances patient safety and optimizes theophylline therapy.